Cornell microbiologists have shown that a single amino acid variation in an enzyme that is part of the DNA copying process of equid herpesvirus type 1 (EHV-1) creates a different type of EHV-1, which causes the neurological disorders in horses. Both types of EHV-1 can also cause abortions.
The researchers' paper is published in the Nov. 9 issue of PLoS Pathogens, published by the Public Library of Science.
The horse herpes virus, a close relative of the chickenpox virus in humans, lives in horses' nostrils and is commonly spread by droplets in the air. And horses remain infected for life. Recently, veterinarians noticed a rise in outbreaks of the neurological form of EHV-1, which can devastate entire herds. Close to one-third of horses that develop the neurological disease end up dying or being euthanized.
"There are apparently two distinct pathotypes of EHV-1 out there, and one is more likely than the other to cause the neurological disease. This study provides the ultimate proof," said Klaus Osterrieder, the paper's senior author who is professor of virology in the Department of Microbiology and Immunology in Cornell's College of Veterinary Medicine. Laura Goodman, who was a graduate student in the Osterrieder laboratory and is now a postdoctoral associate at Cornell's Baker Institute for Animal Health, is the paper's lead author.
After cloning the genome of the virus obtained from a mare that had both lost a fetus and developed neurological symptoms, the researchers then altered one amino acid in the viral enzyme known as DNA polymerase and rendered the virus unable to cause neurological disease. The amino acid change reduced levels of the virus in the horse's bloodstream, and lower levels of the virus reached the central nervous system. The mutation also made the virus more susceptible to antiviral drugs. The researchers believe the reduced replication and levels of virus in the blood may be why one form of the virus does not cause neurological disorders.
"The two pathotypes replicate to similar levels in the horse's nose and spread to other horses with similar efficiency, so interventions should be equally rigorous for all infections," said Osterrieder.
The fact that EHV-1 is a virus and, thus, does not respond to antibiotics underscores the need for prevention, which includes limiting contact and using separate feeders for infected horses. Also, handlers should be careful not to transfer the virus with their clothes, shoes, hands and gear. While vaccines are available that create an immune response against the EHV-1 respiratory disease, no vaccine is currently known to efficiently protect horses against the neurological disease. Only a few vaccines were shown to protect against abortion.
The researchers postulate that herpes viruses evolve toward strains that produce less disease, so they think that the more virulent neurological strain is older than the milder type of EHV-1.
Krishna Ramanujan | EurekAlert!
What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
06.12.2016 | Materials Sciences
06.12.2016 | Medical Engineering
06.12.2016 | Power and Electrical Engineering